Demonstrating Results Equivalence of Bacterial Endotoxins Test Methods

References

1. 1.↵
   1. Seibert F. B.

   The Cause of Many Febrile Reactions following Intravenous Injections I. Am J. Physiol. 1925, 71 (3), 621–651.

   OpenUrl
2. 2.↵
   1. Bourn J. M.,
   2. Seibert F. B.

   The Cause of Many Febrile Reactions following Intravenous Injections. II. The Bacteriology of Twelve Distilled Waters. Am. J. Physiol. 1925, 71 (3), 652–659.

   OpenUrl
3. 3.↵
   1. Hort E. C.,
   2. Penfold W. J.

   Microorganisms and Their Relation to Fever. J. Hyg. 1912, 12 (3), 361–390.

   OpenUrl
4. 4.↵
   1. Probey T. F.,
   2. Pittman M.

   The Pyrogenicity of Bacterial Contaminants Found in Biologic Products. J. Bacteriol. 1945, 50 (4), 397–411.

   OpenUrlFREE Full Text
5. 5.↵
   1. McClosky W. T.,
   2. Price C. W.,
   3. Van Winkle W. Jr.,
   4. Welch H.,
   5. Calvery H. O.

   Results of First U.S.P, Collaborative Study of Pyrogens. J. Am. Pharm. Assoc 1943, 32 (3), 69–73.

   OpenUrl
6. 6.↵
   U.S. Food and Drug Administration. Fed. Regist. 1973, 38 (8), 1404.

   OpenUrl
7. 7.↵
   1. Loverock B.,
   2. Simon B.,
   3. Burgenson A.,
   4. Baines A.

   A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin. Pharmacopeial Forum 2010, 36 (1), 321–329.

   OpenUrl
8. 8.↵
   1. Mizumura H.,
   2. Ogura N.,
   3. Aketagawa J.,
   4. Aizawa M.,
   5. Kobayashi Y.,
   6. Kawabata S-I.,
   7. Oda T.

   Genetic Engineering Approach to Develop Next-Generation Reagents for Endotoxin Quantification. Innate Immun. 2017, 23 (2), 136–146.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Schindler S.,
   2. von Aulock S.,
   3. Daneshian M.,
   4. Hartung T.

   Development, Validation and Applications of the Monocyte Activation Test for Pyrogens Based on Human Whole Blood. ALTEX 2009, 26 (4), 265–277.

   OpenUrlPubMed
10. 10.↵
    U.S. Pharmacopeial Convention, General Notices 6.30 Alternative and Harmonized Methods and Procedures. In USP—NF 2023, USP: Rockville, MD, 2023.
11. 11.↵
    U.S. Pharmacopeial Convention, General Chapter <151> Pyrogen Test. In USP—NF 2023, USP: Rockville, MD, 2023.
12. 12.↵
    U.S. Pharmacopeial Convention, General Chapter <1225> Validation of Compendial Methods. In USP—NF 2023, USP: Rockville, MD, 2023.
13. 13.↵
    U.S. Food and Drug Administration. Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics. FDA Web site. https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf. (accessed March 13, 2024).
14. 14.↵
    U.S. Pharmacopeial Convention, General Chapter <85> Bacterial Endotoxins Test. In USP—NF 2023, USP: Rockville, MD, 2023.
15. 15.↵
    1. Hauck W. W.,
    2. DeStefano A. J.,
    3. Cecil T. L.,
    4. Abernethy D. R.,
    5. Koch W. F.,
    6. Williams R. L.

    Acceptable, Equivalent, or Better: Approaches for Alternatives to Official Compendial Procedures. Pharmacopeial Forum 2009, 35 (3), 772–778.

    OpenUrl
16. 16.↵
    U.S. Pharmacopeial Convention, General Chapter <1223> Validation of Alternative Microbiological Methods. In USP—NF 2023, USP: Rockville, MD, 2023.
17. 17.↵
    U.S. Food and Drug Administration. Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers. FDA Website. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-pyrogen-and-endotoxins-testing-questions-and-answers. (accessed March 13, 2024).
18. 18.↵
    U.S. Pharmacopeial Convention, General Chapter <1010> Analytical Data—Interpretation and Treatment. In USP—NF 2023, USP: Rockville, MD, 2023.
19. 19.↵
    1. Schuirmann D. J.

    A Comparison of the Two One-Sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability. J. Pharmacokinet. Biopharm. 1987, 15 (6), 657–680.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    U.S. Pharmacopeial Convention, General Chapter <1223.1> Validation of Alternative Methods to Antibiotic Microbial Assays. In USP—NF 2023, USP: Rockville, MD, 2023.
21. 21.↵
    1. Lakens D.

    Equivalence Tests: A Practical Primer for t Tests, Correlations, and Meta-Analyses. Social Psychological and Personality Science 2017, 8 (4), 355–362.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Chen L.,
    2. Mozier N.

    Comparison of Limulus Amebocyte Lysate Test Methods for Endotoxin Measurement in Protein Solutions. J. Pharm Biomed Anal. 2013, 80, 180–185.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Piehler M.,
    2. Roeder R.,
    3. Blessing S.,
    4. Reich J.

    Comparison of LAL and rFC Assays – Participation in a Proficiency Test Program between 2014 and 2019. Microorganisms 2020, 8 (3), 418

    OpenUrl
24. 24.↵
    1. Kelley M.,
    2. Stevens I.,
    3. Marchessault N.,
    4. Akiyoshi J.,
    5. Jahngen E. G.

    Evaluation of Recombinant Cascade Reagent PyroSmart NextGen and Limulus Amebocyte Lysate Equivalency in a Plate and Tube Reader for Bacterial Endotoxins Testing. BPB Reports 2023, 6 (1), 11–15.

    OpenUrl
25. 25.↵
    1. Munson T.,
    2. McCullough K.

    Origin and Application of the 50-200% Range in the Bacterial Endotoxins Test. Am. Pharm. Rev. 2023.
26. 26.↵
    1. Burgenson A.

    Comparison of Four Endotoxin Detection Reagents in Measuring Autochthonous Endotoxin Levels in Four Representative Parenteral Products. Pharmaceutical Forum 2023, 49 (2).